MedicarePartD.guide

A non-government resource built from CMS public data

Long-acting (basal) insulin on Wellcare Classic (S4802-086)

Lantus, Basaglar, Tresiba and the other basal insulins, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Indiana + 1 more
Premium
$8.70/month
Deductible
$615.00
Change plan

2 of 7 Long-acting insulin are covered on this plan. None require prior authorization.

5 aren't on the formulary, including Basaglar and Semglee.

Not on the formulary
Basaglar, Semglee, Rezvoglar, Toujeo, Tresiba

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list